Major Depressive Disorder

>

On the HCPLive Major Depressive Disorder condition center page, resources on the topics of medical news and expert insight into depression can be found. Content includes articles, interviews, videos, podcasts, and breaking news on MDD research, treatment, and drug development.

Latest News

Lumateperone Significantly Enhances Antidepressant Effects in Phase 3 Trial
Lumateperone Significantly Enhances Antidepressant Effects in Phase 3 Trial

June 18th 2024

A phase 3 trial shows lumateperone as adjunctive therapy with antidepressants significantly reduces depression symptoms in patients with major depressive disorder.

Persistent Insomnia Symptoms Are Linked to a Greater Depression Risk
Persistent Insomnia Symptoms Linked to a Greater Depression Risk

June 1st 2024

Andrew Krystal, MD | Credit: UCSF Health
Seltorexant Meets Primary, Secondary Endpoints in Phase 3 Trial for MDD, Insomnia

May 30th 2024

NRX-101: First Antidepressant to Lower Suicidality in Bipolar Depression
NRX-101: First Antidepressant to Lower Suicidality in Bipolar Depression

May 29th 2024

Male, Minority Patients Less Frequently Screened for Depression by Primary Care Providers
Male, Minority Patients Less Frequently Screened for Depression by Primary Care Providers

May 18th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.